ReWalk Robotics (NSDQ:RWLK) said yesterday that the U.S. Department of Veterans Affairs issued a policy to evaluate, train and procure its personal exoskeleton systems for all qualifying veterans in the U.S. ReWalk develops and produces exoskeletons designed to restore self-initiated walking for patients with spinal cord injuries. The personal system is battery-powered and features an […]
ReWalk Robotics
Stryker eliminates international prez Subrahmanian’s role | Personnel Moves
Stryker (NYSE:SYK) said yesterday that it’s eliminating the role of international president held by Ramesh Subrahmanian as it reorganizes its overseas business. After Subrahmanian’s departure, effective Dec. 31, he’s slated to stay on until March 31, 2016, as an advisor, Stryker said in a regulatory filing. International sales were down across the board during Stryker’s […]
Reva Medical snags ex-MDT’er Groves for CEO | Personnel Moves
Reva Medical (ASX:RVA) said last week it picked up ex-Medtronic (NYSE:MDT) divisional veep Regina Groves as its new CEO. Groves was vice president and GM of the atrial fibrillation solutions, cardiac rhythm and heart failure division at Medtronic. During her time there, she helped the company strategize a re-entry into the catheter-based atrial fibrillation ablation market, the […]
ReWalk misses Q2 sales mark by a mile, shares plummet
ReWalk Robotics (NSDQ:RWLK) saw shares plummet as it reported 2nd quarter earnings that widely missed analysts marks and larger losses compared to the same quarter last year. ReWalk reported losses of $5.8 million, or 48¢ per share, on sales of $610,000 for the 3 months ended June 30. That amounts to a 23.8% bottom-line loss on […]
JNJ, Google ink robotics deal | Medtech Wall Street news for the week of March 30, 2015
ReWalk Robotics plans Q2 launch in India
(Reuters) — ReWalk Robotics (NSDQ:RWLK) plans to launch its wearable robotic exoskeleton in India by the 2nd quarter, CEO Larry Jasinski said.
Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
Second suitor cedes the field early to Zimmer | Medtech Wall Street news for the week of September 15, 2014
ReWalk Robotics prices IPO at $36M, below range
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
IPOs: ReWalk and NeuroSigma prepare to hit the public market
Two medical device makers are preparing initial public offerings for the coming weeks, breaking up a spree of biotech IPOs that have dominated the market.